Preoperative Systemic Immune-Inflammation Index (SII) for Predicting the Survival of Patients with Stage I-III Gastric Cancer with a Signet-Ring Cell (SRC) Component
Background. Recently, a novel systemic immune-inflammation index (SII) based on peripheral lymphocytes, neutrophils, and platelets has been reported to be correlated with patient prognosis in several malignancies, including gastric cancer. However, the prognostic value of the SII for gastric cancer...
Main Authors: | Ziyu Zhu, Xiliang Cong, Rui Li, Xin Yin, Chunfeng Li, Yingwei Xue |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2020/5038217 |
Similar Items
-
Preoperative Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Stage I-III Gastric Cancer Patients with a MGC Component
by: Ziyu Zhu, et al.
Published: (2021-01-01) -
Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy
by: Yang Li, et al.
Published: (2020-09-01) -
A Rare Presentation of Gastric Signet Ring Cells: Signet Ring Cell Lymphoma
by: Sithara Venkateshwar, et al.
Published: (2014-12-01) -
Preoperative Radiotherapy Is Associated With Significant Survival Benefits for Patients With Gastric Signet Ring Cell Carcinoma: A SEER-Based Approach
by: Hongyun Gong MD, et al.
Published: (2020-09-01) -
The Impact of Perioperative Chemotherapy on Survival in Patients With Gastric Signet Ring Cell Adenocarcinoma
by: Maria João Monteiro de Almeida Baptista Barbosa
Published: (2021)